1. Introduction {#sec1}
===============

Until now, controversies exist regarding the relationship between depression and subsequent cancer risk. That is, some studies showed an increased risk \[[@B1], [@B2]\], but others showed no increased risk \[[@B3], [@B4]\]. Similarly, no specific evidence is available about the relationship between depression and risk of hepatocellular carcinoma (HCC) in older people. In order to explore this issue, a population-based case-control study was conducted to analyze the database from the Taiwan National Health Insurance program.

2. Methods {#sec2}
==========

The details of the Taiwan National Health Insurance program can be documented in previous studies \[[@B5]--[@B7]\]. In this case-control study, we randomly selected 1815 subjects aged 65 years or older with newly diagnosed HCC as the case group (1132 men and 683 women, mean age 74.31 years, and standard deviation 6.29 years) (according to the International Classification of Diseases 9th Revision-Clinical Modification, ICD-9 codes 155, 155.0, and 155.2) and 7260 subjects without HCC as the comparison group (4528 men and 2732 women, mean age 74.09 years, and standard deviation 6.53 years). Both groups were matched with sex, age, and index year of diagnosing HCC, from 2000 to 2010. The index date was defined as the date of diagnosing HCC. In order to reduce the confounding effects, subjects with any cancer (ICD-9 codes 140--208), major psychiatric diseases (ICD-9 codes 291--293, 294.0, 294.8-294.9, 295, 296.0-296.1, 296.4--296.9, and 297-298), other dementia (290.0--290.4, and 294.1), or mental retardation (ICD-9 codes 317--319) diagnosed before the index date were excluded. Depression (ICD-9 codes 331.0) and other comorbidities potentially associated with HCC were diagnosed before the index date \[[@B7]\].

3. Results {#sec3}
==========

We compared the basic characteristics and co-morbidities between the HCC group and the comparison group. [Table 1](#tab1){ref-type="table"} shows that the HCC group was more likely to have diabetes mellitus, cirrhosis, other chronic hepatitis, hepatitis B infection, hepatitis C infection, and alcoholism, with statistical significance. There were 114 subjects with depression among the HCC group (6.28%) and 385 subjects with depression among the comparison group (5.30%), without significant difference (*P* = 0.10). After controlling for confounding factors, multivariable logistic regression analysis demonstrated that the odds ratio (OR) of HCC was 0.81 in subjects with depression (95% confidence interval (CI) = 0.59, 1.11), as compared with nondepressed subjects ([Table 2](#tab2){ref-type="table"}).

4. Discussion {#sec4}
=============

To date, there is no consensus about the association between depression and subsequent cancer risk \[[@B1]--[@B4]\]. One cohort study by Chen and Lin in Taiwan showed that patients with depression correlate with 1.8-fold increased risk of gastrointestinal cancer (95% CI = 1.03, 3.14), but HCC is not mentioned specifically \[[@B2]\]. In the present study, despite the fact that we controlled the comorbidities potentially associated with HCC, no association is detected between depression and HCC risk in older people (OR = 0.81, 95% CI = 0.59, 1.11). Generally speaking, 70--90% of all HCC cases are significantly associated with cirrhosis or other chronic the liver diseases worldwide \[[@B8]\]. Depression is a mood disorder, not causing chronic inflammation of liver. Therefore, these two diseases should have their unique pathogenesis without potential linking. Since formal depression diagnostic procedures were not recorded in this database, more prospective studies are necessary to validate our findings.
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###### 

Characteristics between hepatocellular carcinoma group and comparison group.

                                      Hepatocellular carcinoma   *P* value                  
  ----------------------------------- -------------------------- ----------- ------ ------- ----------
  Age group (year)                                                                           
   65--74                             4260                       58.68       1065   58.68   0.99
   75--84                             3000                       41.32       750    41.32    
  Sex                                                                                        
   Men                                4528                       62.37       1132   62.37   0.99
   Women                              2732                       37.63       683    37.63    
  Comorbidities before index date\*                                                          
   Depression                         385                        5.30        114    6.28    0.10
   Diabetes mellitus                  1941                       26.74       636    35.04   \<0.0001
   Cirrhosis                          137                        1.89        990    54.56   \<0.0001
   Other chronic hepatitis            1163                       16.02       1033   56.91   \<0.0001
   Hepatitis B infection              112                        1.54        361    19.89   \<0.0001
   Hepatitis C infection              135                        1.86        600    33.06   \<0.0001
   Alcoholism                         57                         0.79        24     1.32    0.03

Data are presented as the number of subjects in each group, with percentages given in parentheses.

Chi-square test comparing subjects with and without hepatocellular carcinoma.

\*Comorbidities included before index date were as follows: depression (ICD-9 codes 296.2-296.3, 300.4, and 311), diabetes mellitus (ICD-9 codes 250), cirrhosis (ICD-9 codes 571.2, and 571.5-571.6), other chronic hepatitis (ICD-9 codes 571.40-571.41, 571.49, and 571.8-571.9), hepatitis B infection (ICD-9 codes V02.61, 070.20, 070.22, 070.30, and 070.32), hepatitis C infection (ICD-9 codes V02.62, 070.41, 070.44, 070.51, and 070.54), and alcoholism (ICD-9 codes 303, 305.00, 305.01, 305.02, 305.03, and V11.3).

###### 

Odds ratio and 95% confidence interval of hepatocellular carcinoma associated with depression and other comorbidities.

  Variable                                          Crude   Adjusted^†^              
  ------------------------------------------------- ------- ---------------- ------- ----------------
  Age (per one year)                                1.01    (1.00, 1.01)     1.04    (1.03, 1.05)
  Comorbidities before index date (yes versus no)                                     
   Depression                                       1.20    (0.97, 1.49)     0.81    (0.59, 1.11)
   Diabetes mellitus                                1.48    (1.33, 1.65)     1.04    (0.89, 1.22)
   Cirrhosis                                        62.39   (51.46, 75.65)   28.55   (23.17, 35.19)
   Other chronic hepatitis                          6.93    (6.19, 7.75)     2.23    (1.89, 2.63)
   Hepatitis B infection                            15.84   (12.72, 19.73)   5.87    (4.40, 7.84)
   Hepatitis C infection                            26.06   (21.42, 31.72)   7.72    (6.00, 9.93)
   Alcoholism                                       1.70    (1.05, 2.74)     0.85    (0.43, 1.68)

^†^Adjusted for age, diabetes mellitus, cirrhosis, other chronic hepatitis, hepatitis B infection, hepatitis C infection, and alcoholism.
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